Detalhe da pesquisa
1.
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
J Clin Oncol
; 39(28): 3109-3117, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34170745
2.
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.
J Clin Oncol
; 38(32): 3753-3762, 2020 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822286
3.
The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.
Oral Oncol
; 64: 44-51, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28024723